CA949880A - Pharmaceutical suspension and method of stabilizing - Google Patents

Pharmaceutical suspension and method of stabilizing

Info

Publication number
CA949880A
CA949880A CA064,587A CA64587A CA949880A CA 949880 A CA949880 A CA 949880A CA 64587 A CA64587 A CA 64587A CA 949880 A CA949880 A CA 949880A
Authority
CA
Canada
Prior art keywords
stabilizing
pharmaceutical suspension
pharmaceutical
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA064,587A
Other languages
English (en)
Inventor
William W. Hunter (Jr.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA949880A publication Critical patent/CA949880A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA064,587A 1968-10-14 1969-10-09 Pharmaceutical suspension and method of stabilizing Expired CA949880A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76748068A 1968-10-14 1968-10-14

Publications (1)

Publication Number Publication Date
CA949880A true CA949880A (en) 1974-06-25

Family

ID=25079620

Family Applications (1)

Application Number Title Priority Date Filing Date
CA064,587A Expired CA949880A (en) 1968-10-14 1969-10-09 Pharmaceutical suspension and method of stabilizing

Country Status (6)

Country Link
US (1) US3720761A (de)
CA (1) CA949880A (de)
DE (1) DE1951769A1 (de)
FR (1) FR2020684B1 (de)
GB (1) GB1255670A (de)
NL (1) NL6915452A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048296A (en) * 1975-05-27 1977-09-13 Mallinckrodt, Inc. Radiopharmaceutical scanning agents
US4066742A (en) * 1977-02-14 1978-01-03 Medi-Physics, Inc. Tc-99m sulfur colloid radiopharmaceuticals
US4226846A (en) * 1977-04-01 1980-10-07 New England Nuclear Corporation Albumin microaggregates for radioactive scanning of reticuloendothelial systems
US4337240A (en) * 1978-04-20 1982-06-29 New England Nuclear Corporation Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems
GB2024007B (en) * 1978-06-30 1983-04-27 Gordon R T Cancer-treating composition containing inductively heatable particles
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
DE3105817A1 (de) * 1981-02-18 1982-09-09 Chemische Werke Hüls AG, 4370 Marl Verfahren zur herstellung von polyvinylchlorid und dessen verwendung zur herstellung von folien auf schnellaufenden kalandern
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US5618514A (en) 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
US5071965A (en) * 1988-07-19 1991-12-10 Mallinckrodt Medical, Inc. Novel tc-99m complexes
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143088A (en) * 1937-05-28 1939-01-10 George E Rockwell Therapeutic agent
US2884352A (en) * 1955-03-21 1959-04-28 Schwarz Lab Inc Stable dispersions of colloidal sulfur, processes of preparing same, and sulfur solutions adapted for use in preparing such dispersions

Also Published As

Publication number Publication date
NL6915452A (de) 1970-04-16
FR2020684A1 (de) 1970-07-17
US3720761A (en) 1973-03-13
FR2020684B1 (de) 1974-08-09
GB1255670A (en) 1971-12-01
DE1951769A1 (de) 1970-07-16

Similar Documents

Publication Publication Date Title
CA947679A (en) Method of stabilizing enzymes
CA921875A (en) Package and method of making same
CA949880A (en) Pharmaceutical suspension and method of stabilizing
CA925872A (en) Certain derivatives of pyrazinylmalonates and pyrazineacetic acids
CA948539A (en) Package and method of making same
CA949564A (en) Bis-basic esters and amides of dibenzofuran
CA792243A (en) Triazolidines and process of preparing them
CA798858A (en) Derivatives of 7-d-ribofuranosyl-pyrrolopyrimidines and process therefor
CA777800A (en) Azoniaspironortropine derivatives and methods of making same
CA790629A (en) Method of producing adamantane-2-one and derivatives thereof
CA798583A (en) Pulpstone and method of making
CA775117A (en) Trivinylaluminum and method of making
CA798025A (en) Pulpstone and method of making
CA792770A (en) 2-sulfonamido-thiadiazol derivatives and process of preparing them
CA789542A (en) Modified starch and method of preparation
CA816139A (en) Derivatives of reserpinediol and deserpidinediol
AU433374B2 (en) Method of stabilizing enzymes
CA822125A (en) Thiadiazoles and methods of preparing them
CA817899A (en) Thiadiazoles and methods of preparing them
CA800606A (en) 4-imino-oxazolidin-2-ones and their method of manufacture
CA791113A (en) Method of electropolishing and product
CA823253A (en) Alkenylcyclobutenes and method of preparing same
CA839718A (en) Di-arylene azolyl-stilbenes and method of using same
CA801696A (en) Emulsion and method of making same
CA786941A (en) Electrode and method of making same